News outlets reported that the US Food and Drug Administration (FDA) is releasing the final report of the FDA-funded study that evaluated the risk of blood clots in women using contraceptive pills containing drospirenone. The preliminary report of the study was already discussed in a previous Drug Safety Communication (DSC). The final result of the study will be discussed in a joint meeting of the Reproductive Health Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee on December 8, 2011.
As a Renton personal injury lawyer, I feel it’s essential to keep up-to-date with the news issued by the FDA in order to help spread their information and, hopefully, aid in preventing avoidable injuries. If you’ve suffered injuries or adverse health effects through the use of a defective medical device or drug, contact a personal injury lawyer experienced in these matters to learn more about your rights and the legal avenues open to you.